Kronos Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kronos Bio and other ETFs, options, and stocks.

About KRON

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases.

CEO

Deborah A. Knobelman

CEODeborah A. Knobelman

Employees

Employees10

Headquarters

San Mateo, California

HeadquartersSan Mateo, California

Founded

2017

Founded2017

Employees

Employees10

KRON Key Statistics

Market cap

54.38M

Market cap54.38M

Price-Earnings ratio

-0.84

Price-Earnings ratio-0.84

Dividend yield

—

Dividend yield—

Average volume

1.76M

Average volume1.76M

High today

$0.895

High today$0.895

Low today

$0.875

Low today$0.875

Open price

$0.875

Open price$0.875

Volume

347.54K

Volume347.54K

52 Week high

$1.60

52 Week high$1.60

52 Week low

$0.65

52 Week low$0.65

People also own

Based on the portfolios of people who own KRON. This list is generated using Robinhood data, and it’s not a recommendation.